Novartis
NVS
$13,138
Share price
0.83%
Change (1 day)
57.84%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Market capitalization of Novartis (NVS)
Market cap: $25.209 Trillion
As of January 2026 Novartis has a market cap of $25.209 Trillion. This makes Novartis the world's 54th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Novartis from 1998 to 2026
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2026 | $25.209 T | 5.16% |
| 2025 | $23.973 T | 42.07% |
| 2024 | $16.874 T | -2.33% |
| 2023 | $17.277 T | 7% |
| 2022 | $16.147 T | 10.42% |
| 2021 | $14.623 T | -8.18% |
| 2020 | $15.926 T | 3.96% |
| 2019 | $15.319 T | 11.06% |
| 2018 | $13.794 T | 9.56% |
| 2017 | $12.590 T | 7.11% |
| 2016 | $11.755 T | -15.15% |
| 2015 | $13.853 T | -2.42% |
| 2014 | $14.197 T | 18.07% |
| 2013 | $12.024 T | 44.17% |
| 2012 | $8.340 T | 14.17% |
| 2011 | $7.305 T | 21.13% |
| 2010 | $6.030 T | 3.95% |
| 2009 | $5.801 T | 7.1% |
| 2008 | $5.416 T | 12.23% |
| 2007 | $4.826 T | -19.21% |
| 2006 | $5.973 T | 8.29% |
| 2005 | $5.516 T | 3.85% |
| 2004 | $5.311 T | 3.02% |
| 2003 | $5.156 T | 18.28% |
| 2002 | $4.359 T | -2.86% |
| 2001 | $4.487 T | -17.57% |
| 2000 | $5.444 T | 30.27% |
| 1999 | $4.179 T | -26.77% |
| 1998 | $5.707 T |
End of Day market cap according to different sources
On Jan 19th, 2026 the market cap of Novartis was reported to be:
$25.949 Trillion
$25.209 Trillion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Merck
MRK
|
$24.742 T | -1.85% | ๐บ๐ธ USA |
 Pfizer
PFE
|
$13.274 T | -47.34% | ๐บ๐ธ USA |
 Johnson & Johnson
JNJ
|
$47.952 T | 90.21% | ๐บ๐ธ USA |
 Sanofi
SNY
|
$10.300 T | -59.14% | ๐ซ๐ท France |
 GSK plc
GSK
|
$8.870 T | -64.81% | ๐ฌ๐ง UK |
 Teva Pharmaceutical Industries
TEVA
|
$3.316 T | -86.84% | ๐ฎ๐ฑ Israel |
 Bristol-Myers Squibb
BMY
|
$10.239 T | -59.38% | ๐บ๐ธ USA |
 Abbott Laboratories
ABT
|
$19.289 T | -23.48% | ๐บ๐ธ USA |
 AstraZeneca
AZN
|
$26.649 T | 5.71% | ๐ฌ๐ง UK |